Results 201 to 210 of about 2,074,197 (379)

Multifunctional nanoplatforms based on RNA interference for glioma treatment. [PDF]

Am J Cancer Res
Zhao T, Ju H, Chen Z.
europepmc   +1 more source

RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase [PDF]

, 2002
Olivier Donzé
openalex   +1 more source

Reconstitution of CXCR3+ CCR6+ Th17.1‐Like T Cells in Response to Ofatumumab Therapy in Patients With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Ofatumumab, a fully human anti‐CD20 monoclonal antibody, is effective in reducing relapses and disability progression in patients with multiple sclerosis. This study aimed to examine immune profile changes associated with ofatumumab in a prospective cohort of Chinese patients with relapsing–remitting multiple ...
Shu Yang, Tian‐Xiang Zhang, Jia Liu, Zhirui Liu, Lijie Zhu, Yan‐Yan Li, Bin Feng, Moli Fan, Fu‐Dong Shi, Chao Zhang   +9 more
wiley   +1 more source

Editorial: Non-coding genome and endocrinology: from bench to bedside

Frontiers in Endocrinology, 2023
Radu Pirlog, Kinga Nemeth, George Adrian Calin, George Adrian Calin   +3 more
doaj   +1 more source

Integrating RNA Interference and Nanotechnology: A Transformative Approach in Plant Protection. [PDF]

Plants (Basel)
Islam MS, Ahmed MR, Noman M, Zhang Z, Wang J, Lu Z, Cai Y, Ahmed T, Li B, Wang Y, Golam Sarwar AKM, Wang J.   +11 more
europepmc   +1 more source

Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA [PDF]

, 2002
Federico Calegari, Wulf Haubensak, Dun Yang, Wieland Β. Huttner, Frank Buchholz   +4 more
openalex   +1 more source

Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying functional measures that are both valid and reliable in the limb girdle muscular dystrophy (LGMD) population is critical for quantifying the level of functional impairment related to disease progression in order to establish clinical trial readiness in the context of anticipated therapeutic trials.
Stephanie M. Hunn, Lindsay N. Alfano, Aileen Jones, Amanda Butler, Linda P. Lowes, Megan A. Iammarino, Natalie F. Reash, Lindsay Pietruszewski, Sandhya Sasidharan, Melissa Currence, Jeffrey M. Statland, Talia Strahler, Robert Will, Matthew Wicklund, Stacy Dixon, Renee Augsburger, Tahseen Mozaffar, Katie M. Laubscher, Shelley R. H. Mockler, Katherine D. Mathews, Nikia Stinson, Doris G. Leung, Molly M. Stark, Rebecca A. Horton, Peter B. Kang, Meredith K. James, Amanda Clause, Conrad C. Weihl, Nicholas E. Johnson, GRASP‐LGMD Consortium   +29 more
wiley   +1 more source

Investigational RNA Interference Agents for Hepatitis B. [PDF]

BioDrugs
Hui RW, Mak LY, Seto WK, Yuen MF.
europepmc   +1 more source

Use of double-stranded RNA-mediated interference to determine the substrates of protein tyrosine kinases and phosphatases [PDF]

, 2002
Marco Muda, Carolyn A. Worby, Nancy Simonson-Leff, James C. Clemens, Jack E. Dixon   +4 more
openalex   +1 more source

KIF5A p.Pro986Leu Risk Variant and Accelerated Progression of Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study explored the impact of KIF5A rs113247976 (p.Pro986Leu), a risk allele for amyotrophic lateral sclerosis (ALS), on phenotypic variability in two Italian ALS cohorts (discovery, n = 865; replication, n = 1174). The minor allele (T) frequency was 0.015.
Arianna Manini, Rosario Vasta, Alberto Brusati, Francesco Scheveger, Silvia Peverelli, Alessio Maranzano, Alberto Doretti, Francesco Gentile, Eleonora Colombo, Maura Brunetti, Cristina Moglia, Antonio Canosa, Umberto Manera, Maurizio Grassano, Davide Gentilini, Stefano Messina, Federico Verde, Claudia Morelli, John E. Landers, Bryan J. Traynor, Adriano Chiò, Vincenzo Silani, Andrea Calvo, Antonia Ratti, Nicola Ticozzi   +24 more
wiley   +1 more source